Susquehanna International Group, LLP Kaleido Biosciences, Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$0.05 - $1.7 $2,635 - $89,590	-52,700 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.3 - $2.7 $15,990 - $33,210	-12,300 Reduced 18.92%	52,700 $87,000
Q4 2021 Feb 14, 2022	BUY	$2.39 - $6.02 $76,719 - $193,242	32,100 Added 97.57%	65,000 $155,000
Q3 2021 Nov 15, 2021	BUY	$5.36 - $7.99 $99,696 - $148,614	18,600 Added 130.07%	32,900 $180,000
Q1 2021 May 17, 2021	BUY	$7.2 - $16.82 $102,960 - $240,526	14,300 New	14,300 $116,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.